Pfizer matches Novo bid for obesity biotech Metsera
Digest more
Colossal Biosciences, which has brought to life a small pack of genetically modified dire wolves, has acquired cloning ...
Former chemistry teacher Zhong Huijan’s Hansoh Pharmaceutical Group strikes potentially lucrative licensing deals with big ...
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
The companies Kailera Therapeutics, Summit Therapeutics, and Tubulis bagged the biggest biotech funding rounds overall in ...
Investors have once again turned to Chinese pharmaceutical company Jiangsu Hengrui to create a new biotech startup, this time ...
Evaxion Biotech (NASDAQ: EVAX) is set to give its latest quarterly earnings report on Thursday, 2025-11-06. Here's what ...
Welcome to the Fierce Biotech Graveyard, a yearly ritual where we remember all the biotechs we lost in 2025. While we're ...
Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma First-in-Human Phase 1 ...
3don MSN
Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More Than 130%
Intellia Therapeutics also has fans on Wall Street. The company's current average price target of $32.3 (according to Yahoo!
Biotech is back. Here’s why these rallying stocks belong in your portfolio now. Biotech stocks are emerging from a four-year ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback